Trial intelligence / Profile preview

Azopt vs Placebo added to Xalatan in Elevated IOP

NCT00759941Phase 4Completed

Sponsor
Alcon Inc.
Start
Oct 2007
Primary completion
Jul 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of brinzolamide in open-angle glaucoma (OAG), ocular hypertension, pseudoexfoliation syndrome (PXF), sponsored by Alcon Inc.. Started Oct 2007; status: completed.

02

Drugs

brinzolamide
03

Conditions

open-angle glaucoma (OAG)ocular hypertensionpseudoexfoliation syndrome (PXF)

Beyond the preview

Go deeper on NCT00759941.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00759941.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call